Saturday 17 October 2026
Export LYB’s income statement to Excel — free account
LyondellBasell Industries N.V.
LYB Basic Materials Specialty Chemicals
In the quarter to June 2026, revenue grew 19.8%, EPS grew 388.6%, free cash flow grew 356.4% and total debt rose 9.18%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
64.01
1.34
+2.14%
Follow LYB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.55 | 0.87 | 0.46 | 0.51 | |
P/FCF ratio |
9.95 | 24.97 | 27.07 | 19.59 | |
P/Operating CF |
22.61 | (96.43) | 9.25 | 16.06 | |
P/B ratio |
1.59 | 2.58 | 1.38 | 1.49 | |
Price to Tangible BV |
1.78 | 2.91 | 1.56 | 1.67 | |
EV/Sales |
0.87 | 1.22 | 0.78 | 0.84 | |
EV/EBITDA |
11.37 | 32.17 | 23.89 | 54.41 | |
EV/Operating CF |
9.17 | 14.08 | 10.36 | 9.68 | |
EV/FCF |
15.96 | 34.86 | 45.50 | 32.07 | |
Quick Ratio |
0.93 | 0.82 | 0.97 | 0.70 | |
Current Ratio |
1.64 | 1.54 | 1.77 | 1.57 | |
Net Debt/EBITDA |
5.43 | 17.61 | 31.63 | (26.60) | |
Debt/Assets |
37.44% | 38.05% | 38.05% | 35.09% | |
Debt/Equity |
1.21 | 1.29 | 1.28 | 1.12 | |
Asset Turnover |
0.89 | 0.86 | 0.86 | 0.87 | |
Operating CF/Net income |
1.35 | (2.19) | (10.61) | (1.10) | |
Capex/Depreciation |
(0.77) | (0.78) | (0.82) | (1.15) | |
Interest Coverage |
11.18 | 1.73 | (0.67) | (5.62) | |
Research and Development Expense of Revenue |
0.37% | 0.50% | 0.47% | 0.44% | |
Selling, General and Administrative Expense of Revenue |
4.22% | 5.71% | 5.26% | 5.19% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
0.21% | 0.65% | 0.30% | 0.19% | |
Graham Net Nets |
(0.71) | (0.50) | (0.94) | (0.79) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.15%) | (3.09%) | (5.38%) | (7.65%) | |
Free Cash Flow Yield |
10.05% | 4.01% | 3.69% | 5.10% | |
Revenue per Share |
28.41 | 22.35 | 22.02 | 24.00 | |
Operating CF per Share |
2.33 | (0.84) | 4.68 | 3.05 | |
Capex per Share |
(0.84) | (0.84) | (0.99) | (1.26) | |
Free Cash Flow per Share |
1.49 | (1.67) | 3.69 | 1.79 | |
Cash per Share |
8.17 | 8.20 | 10.71 | 5.59 | |
Shareholders Equity per Share |
33.07 | 31.21 | 31.34 | 32.95 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
33.07 | 31.21 | 31.34 | 32.95 | |
Free Cash Flow |
482.00 | (538.00) | 1,188.00 | 577.00 | |
Working Capital |
4,558.00 | 3,869.00 | 4,739.00 | 3,905.00 | |
Capital Expenditures |
(270.00) | (269.00) | (319.00) | (406.00) | |
Net Current Asset Value |
(12,137.00) | (12,850.00) | (13,042.00) | (12,420.00) | |
EV/EBIT |
28.32 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.05 | 0.05 | |
Price to Operating Income |
17.66 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3,586.50 | 3,524.50 | 2,904.50 | 3,484.00 | |
Average Payables |
3,173.00 | 3,280.00 | 3,213.00 | 3,277.00 | |
Average Inventory |
4,323.50 | 4,282.50 | 4,095.50 | 4,835.00 | |
Average Assets |
34,917.00 | 34,573.50 | 34,874.50 | 35,525.00 | |
Average Common Equity |
11,300.50 | 11,136.00 | 11,283.50 | 12,169.00 |
Columns are period end dates